Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Publications indexed to the term Wet Macular Degeneration

FacultyTitle
1Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD. (Reid CA, Nettesheim ER, Connor TB, Lipinski DM) Sci Rep 2018 Aug 06;8(1):11763       58 Citations
2NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH ADVANCED VISUAL LOSS TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: Clinical Outcome and Prognostic Indicators. (Vogel RN, Davis DB, Kimura BH, Rathinavelu S, Graves GS, Szabo A, Han DP) Retina 2017 Feb;37(2):257-264       8 Citations
1Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study. (Boyer DS, Goldbaum M, Leys AM, Starita C, V.I.S.I.O.N. Study Group) Br J Ophthalmol 2014 Nov;98(11):1543-6       17 Citations
1Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. (Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, Clemons TE, Sangiovanni JP, Danis RP, Ferris FL 3rd, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agrón E, Toth CA, Bernstein PS, Sperduto RD) JAMA Ophthalmol 2014 Feb;132(2):142-9       386 Citations
1Age-related macular degeneration, anti-VEGF therapy, and ophthalmic imaging: is there a best practice? (Han DP) JAMA Ophthalmol 2013 Sep;131(9):1124-6       7 Citations
1Ranibizumab treatment outcomes in phakic versus pseudophakic eyes: an individual patient data analysis of 2 phase 3 trials. (Weinberg DV, Shapiro H, Ehrlich JS) Ophthalmology 2013 Jun;120(6):1278-82       14 Citations
1Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study. (Friberg TR, Tolentino M, LEVEL Study Group, Weber P, Patel S, Campbell S, Goldbaum M) Br J Ophthalmol 2010 Dec;94(12):1611-7       49 Citations